King Pharmaceuticals KG Program Services — Reinsurance balances receivable, net

Other segment segments

Legacy Reinsurance

$297K—

Similar metrics at other companies

MKLProgram Services — Reinsurance recoverables on unpaid losses, end of year

$1.3B—

MKLProgram Services — Liability for Unpaid Claims and Claims Adjustment Expense, Net

$0—

HMNReinsurance balances receivable

$421.5M+2.1%

EQHReinsurance balances payable

$1.31B-3.8%

AFGReinsurance balances payable

$1.07B+3.6%

SAFTReinsurance balances payable

$1.89M-90.8%

Other financials

Income statement

See full

Revenue$10.2M+1,112%

Net income-$7.4M-1,786%

EPS (diluted)-$0.96-586%

Balance sheet

See full

Cash & equivalents$62.2M+1,724%

Total debt$176.7M—

Total equity$121.4M+2,773%

Total assets$964.2M—

Cash flow

See full

Operating cash flow-$15.1M-1,628%

Valuation

See full

Market cap$70.42M-67.6%

Enterprise value$184.93M-50.0%

P/E1.2×—

P/S1.6×-24.3×

Profitability

See full

Net margin131.5%—

Returns & leverage

See full

Return on equity90.8%—

Debt / equity1.5×—

Where this comes from

Reported directly by King Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:PremiumsReceivableAtCarryingValue.

The official record: King Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about King Pharmaceuticals's program services — reinsurance balances receivable, net.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Claude

Questions, answered.

What is King Pharmaceuticals's program services — reinsurance balances receivable, net?: King Pharmaceuticals (KG) reported program services — reinsurance balances receivable, net of $0 in Q1 2026.
What does program services — reinsurance balances receivable, net mean?: Amounts due from reinsurers for paid losses and other contractual obligations, net of any payables to those reinsurers. This reflects the segment's credit exposure to its reinsurance partners.